AN Pharma Consulting AB

Active
559336-5801Limited company (AB)Registered 2021STOCKHOLM

Key figures

2 572 113 kr
Revenue 2025
01 m2 m3 m202320242025

Key figures

2025

Summary: AN Pharma Consulting AB

What kind of company is it?

AN Pharma Consulting AB (org. no. 559336-5801) is a limited company (AB). The company was registered in 2021 and has existed for 5 years. Registered seat: Stockholm. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).

How is the company doing financially?

Net sales in financial year 2025 were 2 572 113 kr. Net profit for 2025 was 869 658 kr (33,8 % of net sales). The company was profitable in 1 of the 3 reported financial years. Employees in financial year 2025: 1 (previous year: 0). Net sales per employee were 2 572 113 kr. At the end of financial year 2025, total assets were 1 639 028 kr and equity 953 171 kr (equity ratio 58,2 %). The annual report for 2025 proposes a dividend of 450 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. The LEI code (636700RC437CBRXFP254) comes from the GLEIF database. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 450 000 kr.

History
2025450 000 kr
20240 kr
Summary of annual reports2023–2025
202320242025
Sales revenue002 572 113
Profit for the reporting year−1 073−10 155869 658
Retained earnings of previous periods———
Total assets43 66838 5191 639 028
Total liabilities05 006685 857
Total equity43 66833 513953 171
Employees001
Proposed dividend—0450 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.